Arun Kumar Radhakrishnan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Arun Kumar Radhakrishnan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Abinaya Elango
Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education
1 shared publication- Antara Banerjee
Medical Biotechnology Lab, Faculty of Allied Health Sciences, Chettinad Academy of Research and Education (CARE), Chettinad Hospital and Research Institute (CHRI), Chennai, India
1 shared publication - Asim K. Duttaroy
Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo
1 shared publication D. Prabhu
1 shared publication- Diptimayee Das
Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam, Chennai 603103, Tamil Nadu, India
1 shared publication Divya Ilanchoorian
Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education
1 shared publication
Latest Publications
- 2 January 2023
- Published by Springer Nature
- p. 153-173
Aging Gut Microbiota and Chronic Kidney Disease
- Open Access
- 10 March 2022
- Published by MDPI AG in Preprints.org
Non-Hemostatic Functions of Human Blood Platelets: Effects of Bioactive Compounds
Platelets have long been associated with sustaining the balance between hemostasis and thrombosis. Platelets, however, are also involved in a wide range of biological activities, including inflammation, immunology, wound healing, cancer biology, and angiogenesis. Platelets' diverse roles are mediated by the expression of various adhesive and immune receptors and the secretion of a diverse array of bioactive proteins, ions stored in granules, and several lipid mediators. Platelets also release pro-inflammatory and anti-inflammatory, and angiogenic factors and shed microparticles into the bloodstream. The challenge for therapeutic intervention in non-hemostatic disease is identifying the factors that primarily inhibit specific targets implicated in platelets' complicated contribution to inflammation or tumor growth while leaving their hemostatic function intact. In addition, blood platelets are involved in infection and innate and adaptive immunity by mediating complicated vascular homeostasis via specialized receptors and granule release, RNA transfer, and mitochondrial secretion. Anti-platelet drugs/bioactive compounds are developed based on their platelet anti-aggregatory properties; however, very little information is available on their effects on non-hemostatic function. Therefore, a better understanding of the impact of the anti-platelet bioactive on the platelets' diverse roles and mechanisms may help develop new strategies and prevent CVD and other diseases. In this review, a comprehensive overview of platelet multifunctional roles in CVD and other diseases and dietary factors' modulatory effects are described.
- 10 March 2022
- Published by MDPI AG in Preprints.org
Open AccessNon-Hemostatic Functions of Human Blood Platelets: Effects of Bioactive Compounds
Platelets have long been associated with sustaining the balance between hemostasis and thrombosis. Platelets, however, are also involved in a wide range of biological activities, including inflammation, immunology, wound healing, cancer biology, and angiogenesis. Platelets' diverse roles are mediated by the expression of various adhesive and immune receptors and the secretion of a diverse array of bioactive proteins, ions stored in granules, and several lipid mediators. Platelets also release pro-inflammatory and anti-inflammatory, and angiogenic factors and shed microparticles into the bloodstream. The challenge for therapeutic intervention in non-hemostatic disease is identifying the factors that primarily inhibit specific targets implicated in platelets' complicated contribution to inflammation or tumor growth while leaving their hemostatic function intact. In addition, blood platelets are involved in infection and innate and adaptive immunity by mediating complicated vascular homeostasis via specialized receptors and granule release, RNA transfer, and mitochondrial secretion. Anti-platelet drugs/bioactive compounds are developed based on their platelet anti-aggregatory properties; however, very little information is available on their effects on non-hemostatic function. Therefore, a better understanding of the impact of the anti-platelet bioactive on the platelets' diverse roles and mechanisms may help develop new strategies and prevent CVD and other diseases. In this review, a comprehensive overview of platelet multifunctional roles in CVD and other diseases and dietary factors' modulatory effects are described.
- 1 January 2020
- Published by Africa Health Research Organization
- Vol. 23 (15)
Acute Oral Toxicity study of ViproTM Polyherbal Formulation in Wistar albino rats
- 1 January 2020
- Published by Africa Health Research Organization
- Vol. 23 (15)
Acute Oral Toxicity study of ViproTM Polyherbal Formulation in Wistar albino rats